Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Inventory (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Inventory for 13 consecutive years, with $137.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory fell 9.94% year-over-year to $137.3 million, compared with a TTM value of $137.3 million through Sep 2025, down 9.94%, and an annual FY2024 reading of $149.6 million, down 5.27% over the prior year.
  • Inventory was $137.3 million for Q3 2025 at Tandem Diabetes Care, down from $142.6 million in the prior quarter.
  • Across five years, Inventory topped out at $161.7 million in Q2 2024 and bottomed at $65.7 million in Q3 2021.
  • Average Inventory over 5 years is $119.5 million, with a median of $137.3 million recorded in 2025.
  • The sharpest move saw Inventory surged 67.54% in 2023, then decreased 11.81% in 2025.
  • Year by year, Inventory stood at $68.6 million in 2021, then surged by 62.09% to $111.1 million in 2022, then surged by 42.14% to $157.9 million in 2023, then decreased by 5.27% to $149.6 million in 2024, then dropped by 8.24% to $137.3 million in 2025.
  • Business Quant data shows Inventory for TNDM at $137.3 million in Q3 2025, $142.6 million in Q2 2025, and $141.2 million in Q1 2025.